Quadrant Capital Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$959 Sell
160
-1,057
-87% -$7.95K ﹤0.01% 2591
2025
Q4
$8.73K Sell
1,217
-9,606
-89% -$75.9K ﹤0.01% 2240
2025
Q3
$116K Buy
+10,823
New +$106K ﹤0.01% 1441
2025
Q2
Sell
-53,909
Closed -$803K 2189
2025
Q1
$803K Buy
53,909
+42,454
+371% +$653K 0.03% 476
2024
Q4
$171K Sell
11,455
-6,892
-38% -$112K 0.01% 770
2024
Q3
$351K Sell
18,347
-635
-3% -$13.2K 0.02% 452
2024
Q2
$393K Buy
18,982
+922
+5% +$18.3K 0.03% 391
2024
Q1
$340K Buy
18,060
+6,596
+58% +$113K 0.03% 435
2023
Q4
$165K Buy
11,464
+10,597
+1,222% +$144K 0.01% 709
2023
Q3
$15.1K Sell
867
-221
-20% -$4.61K ﹤0.01% 1824
2023
Q2
$22.6K Sell
1,088
-188
-15% -$4.09K ﹤0.01% 1657
2023
Q1
$30K Buy
1,276
+245
+24% +$6.58K ﹤0.01% 1492
2022
Q4
$28.8K Sell
1,031
-215
-17% -$5.5K ﹤0.01% 1478
2022
Q3
$29K Sell
1,246
-207
-14% -$6.25K ﹤0.01% 1344
2022
Q2
$49K Sell
1,453
-205
-12% -$7.18K 0.01% 875
2022
Q1
$58K Buy
1,658
+22
+1% +$752 0.01% 863
2021
Q4
$50K Buy
1,636
+15
+0.9% +$489 0.01% 927
2021
Q3
$53K Sell
1,621
-273
-14% -$8.73K 0.01% 838
2021
Q2
$57K Buy
+1,894
New +$62.3K 0.01% 798

Other funds holding OGN

Quadrant Capital Group's OGN Position: Q1 2026 in Review

Quadrant Capital Group reduced its Organon & Co (OGN) stake by 87% in Q1 2026, selling an estimated $7.95K and leaving 160 shares worth $959. The position accounts for ﹤0.01% of the portfolio, ranked #2591.

Quadrant Capital Group first reported a position in OGN in Q2 2021 and has held it in 19 quarters since. The position peaked at $803K in Q1 2025. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Quadrant Capital Group held 160 shares of Organon & Co worth $959 as of Q1 2026.
  • Quadrant Capital Group sold 1,057 Organon & Co shares in Q1 2026, an estimated $7.95K.
  • Organon & Co made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #2591 holding.
  • Quadrant Capital Group first reported a position in Organon & Co in Q2 2021 and has held it in 19 quarters since.
  • Quadrant Capital Group's Organon & Co position peaked at $803K in Q1 2025.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.